Tag: Harm reduction

INHSU 2019: Wholistic hepatitis C care, and the importance of care providers

Hundreds of clinicians, researchers and people with lived experience gathered in Montreal in September 2019 to highlight promising work in hepatitis C research and practice. The 8th International Conference on Hepatitis Care in Substance Users (INHSU 2019) showcased innovative models of care that support the delivery of hepatitis C treatment.

Read more

Meeting people where they are is about much more than location: Delivering hepatitis C care and treatment to people who use drugs

Poverty, stigma and criminalization are chronic problems among people who use and inject drugs. But hepatitis C virus (HCV) is no longer such a problem, since it is usually cured by eight to 12 weeks of oral, direct-acting antivirals (DAAs). Delivering DAAs to people who use and inject drugs in the context of the chronic problems facing them is an opportunity to recognize and support the contribution of people with lived experience, and to build and strengthen systems and programs.

Read more

Can Halifax open Atlantic Canada’s first legal overdose prevention site? Yes, we can!

This blog post is a follow-up from an earlier post published on July 11, 2019. As I work on a new funding proposal, this statement strikes me: over 11,500 people in Canada have lost their lives as a result of opioid-related overdoses between January 2016 and December 2018 and we keep losing people every day. So many lives lost! And why is that? The evidence is clear that overdose prevention sites save lives! After I returned from a hands-on training in the Downtown East Side of Vancouver, one of the hardest hit places in the overdose crisis, it became even...

Read more